Back to Results

Pennant Group Inc (PNTG)

Pennant Group Inc (PNTG) is a NASDAQ-listed common stock in the healthcare sector, with a focus on healthcare providers and services. The security context is common equity, so it represents an ownership interest in the company rather than a separate instrument. Pennant Group Inc is associated with services for people who need clinical support, end-of-life care, or assistance in residential senior settings. Its business profile is tied to care delivery across home-based, hospice, and senior living arrangements. As a listed healthcare company, it is part of a regulated industry that serves patients and older adults through a mix of clinical and supportive services.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-PNTG
$38.09
-3.4% Downside
Fair
$46.67
18.3% Upside
Undervalued
Great
0.0%
November 9, 2026
42.1x
3.8x
1.2x
1.377 B
1.859 B
26.1%
95.1%
3.8
80.7%
Valuation • Fair Value

Pennant Group Inc (NASDAQ-PNTG) Fair Value by Valuation Model

Review the available estimates for Pennant Group Inc (NASDAQ-PNTG), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$38.09

Estimated downside of 3.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$38.52

Discounted cash flow valuation reference.

Ben Graham Formula Value

$10.27

Classic Ben Graham valuation formula reference.

Comps Fair Value

$37.66

Comparable-company valuation reference.

Analyst Price Target

$46.67

Analysts imply upside of 18.3%.

How to read these valuation models

Use the 6 available valuation references for Pennant Group Inc (NASDAQ-PNTG) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Pennant Group Inc (NASDAQ-PNTG)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.102 B

Current operating scale indicator.

Revenue Forecast

1.184 B

Forward revenue estimate.

EBITDA

74.57 M

Current operating profitability reference.

EBITDA Forecast

96.3 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Pennant Group Inc (NASDAQ-PNTG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Pennant Group Inc (NASDAQ-PNTG)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-2.17

Intermediate zone that deserves monitoring.

Altman Z-Score

3.8

Relatively strong balance-sheet zone.

FCF / Net Income

80.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Pennant Group Inc (NASDAQ-PNTG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Pennant Group Inc (NASDAQ-PNTG)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 9, 2026

Days to Earnings

48

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Pennant Group Inc (NASDAQ-PNTG), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Pennant Group Inc (NASDAQ-PNTG) Stock Forecast & Technical Outlook

Review Pennant Group Inc (NASDAQ-PNTG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Pennant Group Inc (NASDAQ-PNTG) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Pennant Group Inc (NASDAQ-PNTG) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Pennant Group Inc (NASDAQ-PNTG) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Pennant Group Inc (NASDAQ-PNTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Pennant Group Inc (NASDAQ-PNTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Pennant Group Inc (NASDAQ-PNTG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Pennant Group Inc (NASDAQ-PNTG) has a Strong Buy consensus, with 6 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 6
Hold 0
Sell 0
FAQ • Fast Investor Answers

Pennant Group Inc (NASDAQ-PNTG) Stock FAQ

Data-supported answers about Pennant Group Inc (NASDAQ-PNTG), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$38.09
Estimated downside 3.4%
Valuation Rating
Overvalued
Estimated downside of 3.4%
Analyst Target
$46.67
Implied upside 18.3%
Financial Health
Great
Current financial-health read

The current fair value estimate for Pennant Group Inc (NASDAQ-PNTG) is $38.09. This implies an estimated downside of 3.4% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 3.4% versus the current market price.

The available analyst price target for Pennant Group Inc (NASDAQ-PNTG) is $46.67. The analyst target implies estimated upside of 18.3%.

The current financial health read for Pennant Group Inc (NASDAQ-PNTG) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Pennant Group Inc (NASDAQ-PNTG) is November 9, 2026.

The latest available data indicates no current dividend yield for Pennant Group Inc (NASDAQ-PNTG).

The current P/E ratio listed for Pennant Group Inc (NASDAQ-PNTG) is 42.1x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Pennant Group Inc is 1.377 B.

The current enterprise value listed for Pennant Group Inc is 1.859 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Pennant Group Inc is NASDAQ-PNTG, and the stock is listed on NASDAQ.

Pennant Group Inc (NASDAQ-PNTG) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Pennant Group Inc is 26.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Pennant Group Inc is 95.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B